Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
96 rows where has_known_aptamer = 1, surface_class = "A_assoc" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
tier 1
- Tier 1.5 · 96 ✖
surface_class 1
- A_assoc · 96 ✖
has_known_aptamer 1
- 1 · 96 ✖
has_activation_state_pdb_pair 1
- 0 96
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P07225 | PROS1 | Vitamin K-dependent protein S | Tier 1.5 | 0.847 | 1 | A_assoc | 3 | 82.94 | 1 | 0 | 1 | 2 | 36859809, 33674695 | 1 | thrombophilia due to protein S deficiency, autosomal dominant | 0.8240418292042652 | ||
| P39060 | COL18A1 | Collagen alpha-1(XVIII) chain | Tier 1.5 | 0.836 | 1 | A_assoc | 9 | 50.62 | 1 | 0 | 1 | 2 | 36707842, 23679916 | 1 | Knobloch syndrome 1 | 0.7867122552672962 | ||
| P35625 | TIMP3 | Metalloproteinase inhibitor 3 | Tier 1.5 | 0.831 | 1 | A_assoc | 1 | 87.0 | 0 | 0 | 1 | 3 | 42105605, 36768220 | 1 | Sorsby fundus dystrophy | 0.7684253675298044 | ||
| P02748 | C9 | Complement component C9 | Tier 1.5 | 0.829 | 1 | A_assoc | 9 | 78.75 | 1 | 0 | 1 | 10 | 41636061, 40411682, 36428893, 36290981, 35247355, 28794177, 27836219, 22678933, 19261617, 15687383 | 1 | Immunodeficiency due to a late component of complements deficiency | 0.761965409699055 | ||
| P36955 | SERPINF1 | Pigment epithelium-derived factor | Tier 1.5 | 0.811 | 1 | A_assoc | 3 | 90.12 | 0 | 0 | 1 | 17 | 41503480, 40965986, 24311895, 21546514, 19668729, 17628122, 16787141, 16724865, 16136393, 15947805 | 1 | osteogenesis imperfecta | 0.701995723393119 | ||
| O00187 | MASP2 | Mannan-binding lectin serine protease 2 | Tier 1.5 | 0.81 | 1 | A_assoc | 10 | 89.44 | 0 | 0 | 1 | 1 | 40371468 | 1 | immunodeficiency due to MASP-2 deficiency | 0.6996393077218865 | ||
| Q16270 | IGFBP7 | Insulin-like growth factor-binding protein 7 | Tier 1.5 | 0.785 | 1 | A_assoc | 1 | 84.44 | 0 | 0 | 1 | 4 | 41192243, 27679852, 41280530 | 1 | familial retinal arterial macroaneurysm | 0.6182241349863704 | ||
| Q99988 | GDF15 | Growth/differentiation factor 15 | Tier 1.5 | 0.775 | 1 | A_assoc | 4 | 75.69 | 1 | 0 | 1 | 29 | 41924874, 41862097, 38879214, 38477735, 37982669, 36927042, 36638554, 36508319, 36333824, 35762561, 33334063, 32527800, 31988066, 29992704, 39884764, 38497478, 38296402, 37162508, 32739349, 30335547 | 1 | hyperemesis gravidarum | 0.5821658682742563 | ||
| P10451 | SPP1 | Osteopontin | Tier 1.5 | 0.772 | 1 | A_assoc | 3 | 53.41 | 0 | 0 | 1 | 62 | 41690559, 41223977, 39422353, 38600327, 32943056, 32042311, 31603904, 30307407, 28916037, 28453726, 25278703, 21147843, 42136308, 42108056, 40845664, 40479828, 39677448, 39340832, 38834269, 37162508, 36508319, 36284815, 35433114, 35190123, 34420232, 32166466, 31987218, 31879964, 31806966, 31301870, 30135425, 29441346, 28988933, 28706912, 26529285, 25949891, 25930003, 25713073, 24902765, 24491763, 24438228, 23889968, 23619316, 22880609, 22241292, 21962803, 21801960, 20967826, 19570203, 18985031 | 1 | osteoporosis | 0.5729473764531288 | ||
| P10646 | TFPI | Tissue factor pathway inhibitor | Tier 1.5 | 0.768 | 1 | A_assoc | 9 | 73.62 | 1 | 0 | 1 | 28 | 32366845, 32224381, 30994257, 30302740, 27563744, 27196067, 24263002, 23528042, 22951415, 22658294, 22632032, 22239993, 21696535, 21389323, 8578509, 25521966, 24319161 | 1 | hemophilia A | 0.5591056672248635 | ||
| P10909 | CLU | Clusterin | Tier 1.5 | 0.766 | 1 | A_assoc | 2 | 77.31 | 0 | 0 | 1 | 5 | 42041411, 37179603, 36980195, 35383192, 26061649 | 1 | Alzheimer disease | 0.5545645077431476 | ||
| P13497 | BMP1 | Bone morphogenetic protein 1 | Tier 1.5 | 0.766 | 1 | A_assoc | 8 | 81.44 | 0 | 0 | 1 | 1 | 39939919 | 1 | osteogenesis imperfecta | 0.5547577676549571 | ||
| P02771 | AFP | Alpha-fetoprotein | Tier 1.5 | 0.765 | 1 | A_assoc | 5 | 88.94 | 1 | 0 | 1 | 195 | 41849903, 41732103, 41688234, 41327249, 41051792, 40839965, 40750207, 40684729, 40578247, 40383027, 40381048, 40347636, 40262341, 40216053, 39982565, 39942588, 39890683, 39771616, 39479488, 39383727, 39305942, 39167423, 39140150, 39082193, 39067928, 39007743, 38904836, 38852341, 38356334, 37836778, 37709445, 37606762, 37366993, 37303825, 37295202, 37284243, 37228865, 37104032, 36989661, 36979562, 36842207, 36693188, 36512161, 36389169, 36290918, 36240195, 36130652, 35969067, 35793076, 35747812, 41637558, 41575587, 41123957, 41103270, 40349714, 40286895, 38899396, 37325361 | 1 | Congenital deficiency in alpha-fetoprotein | 0.5500580170557311 | ||
| P55145 | MANF | Mesencephalic astrocyte-derived neurotrophic factor | Tier 1.5 | 0.761 | 1 | A_assoc | 3 | 81.69 | 0 | 0 | 1 | 1 | 12698297 | 1 | diabetes, deafness, developmental delay, and short stature syndrome | 0.5377386885662411 | ||
| P24593 | IGFBP5 | Insulin-like growth factor-binding protein 5 | Tier 1.5 | 0.711 | 1 | A_assoc | 3 | 76.06 | 1 | 0 | 1 | 4 | 39317671, 31930684 | 1 | hypothyroidism | 0.3702458751451027 | ||
| Q00604 | NDP | Norrin | Tier 1.5 | 0.707 | 1 | A_assoc | 11 | 83.56 | 1 | 0 | 1 | 2 | 39057719, 11352723 | 0 | Norrie disease | 0.8566451682188412 | ||
| O43866 | CD5L | CD5 antigen-like | Tier 1.5 | 0.706 | 1 | A_assoc | 4 | 85.88 | 1 | 0 | 1 | 3 | 40215752, 37100807 | 1 | functional neutrophil defect | 0.3529395470693119 | ||
| P10145 | CXCL8 | Interleukin-8 | Tier 1.5 | 0.706 | 1 | A_assoc | 21 | 88.06 | 1 | 0 | 1 | 15 | 39564692, 35821507, 31985806, 29268188, 41866852, 37732574, 37016361, 36037714, 35197258, 34884636, 25998051, 24129312 | 1 | coronary artery disease | 0.35357870191996843 | ||
| P22692 | IGFBP4 | Insulin-like growth factor-binding protein 4 | Tier 1.5 | 0.706 | 1 | A_assoc | 4 | 77.25 | 0 | 0 | 1 | 6 | 35323639, 32515246, 31930684 | 1 | allergic rhinitis | 0.35214760515440524 | ||
| P12273 | PIP | Prolactin-inducible protein | Tier 1.5 | 0.701 | 1 | A_assoc | 1 | 89.69 | 0 | 0 | 1 | 7 | 41440247, 36179084, 35726753, 35336001, 28107930, 26297462, 21559755 | 1 | neurodegenerative disease | 0.3382059336442212 | ||
| P80162 | CXCL6 | C-X-C motif chemokine 6 | Tier 1.5 | 0.699 | 1 | A_assoc | 2 | 81.0 | 1 | 0 | 1 | 3 | 40008515, 36649818, 32628701 | 1 | neurodegenerative disease | 0.3309117033683961 | ||
| P98066 | TNFAIP6 | Tumor necrosis factor-inducible gene 6 protein | Tier 1.5 | 0.693 | 1 | A_assoc | 5 | 81.12 | 0 | 0 | 1 | 1 | 39263947 | 1 | type 2 diabetes mellitus | 0.30862220597837015 | ||
| Q13253 | NOG | Noggin | Tier 1.5 | 0.685 | 1 | A_assoc | 2 | 86.06 | 0 | 0 | 1 | 2 | 38397086 | 0 | proximal symphalangism 1A | 0.7844136456463046 | ||
| P03971 | AMH | Anti-Muellerian hormone | Tier 1.5 | 0.685 | 1 | A_assoc | 3 | 68.62 | 1 | 0 | 1 | 2 | 41101154, 27364573 | 0 | persistent Mullerian duct syndrome | 0.7847328444470535 | ||
| P01138 | NGF | Beta-nerve growth factor | Tier 1.5 | 0.684 | 1 | A_assoc | 8 | 73.25 | 0 | 0 | 1 | 6 | 42015870, 38780008, 32982626, 21216401, 7545283, 29754498 | 0 | hereditary sensory and autonomic neuropathy type 5 | 0.7785402119369383 | ||
| P18510 | IL1RN | Interleukin-1 receptor antagonist protein | Tier 1.5 | 0.682 | 1 | A_assoc | 5 | 87.06 | 0 | 0 | 1 | 1 | 38928037 | 0 | sterile multifocal osteomyelitis with periostitis and pustulosis | 0.7734282711738736 | ||
| O15520 | FGF10 | Fibroblast growth factor 10 | Tier 1.5 | 0.67 | 1 | A_assoc | 2 | 80.0 | 0 | 0 | 1 | 1 | 35415885 | 0 | Lacrimoauriculodentodigital syndrome | 0.7344198619465704 | ||
| O00300 | TNFRSF11B | Tumor necrosis factor receptor superfamily member 11B | Tier 1.5 | 0.666 | 1 | A_assoc | 1 | 86.5 | 0 | 0 | 1 | 1 | 15562003 | 0 | juvenile Paget disease | 0.7184894548525037 | ||
| P19835 | CEL | Bile salt-activated lipase | Tier 1.5 | 0.658 | 1 | A_assoc | 7 | 82.56 | 0 | 0 | 1 | 2 | 39653009, 34940276 | 0 | MODY | 0.6940743944678538 | ||
| Q9Y5C1 | ANGPTL3 | Angiopoietin-related protein 3 | Tier 1.5 | 0.652 | 1 | A_assoc | 1 | 79.62 | 0 | 0 | 1 | 1 | 23770039 | 0 | familial hypobetalipoproteinemia 2 | 0.6739043862507132 | ||
| O75594 | PGLYRP1 | Peptidoglycan recognition protein 1 | Tier 1.5 | 0.649 | 1 | A_assoc | 1 | 91.0 | 0 | 0 | 1 | 2 | 35821507, 33534888 | 1 | dementia | 0.16478389504231422 | ||
| P02776 | PF4 | Platelet factor 4 | Tier 1.5 | 0.635 | 1 | A_assoc | 10 | 75.06 | 0 | 0 | 1 | 10 | 33859620, 32366845, 31967847, 23847186, 23673861, 34248840, 32022468 | 1 | systemic scleroderma | 0.11523541376593864 | ||
| O76093 | FGF18 | Fibroblast growth factor 18 | Tier 1.5 | 0.631 | 1 | A_assoc | 1 | 87.56 | 0 | 0 | 1 | 1 | 35415885 | 0 | cancer | 0.6028027301556572 | ||
| P08620 | FGF4 | Fibroblast growth factor 4 | Tier 1.5 | 0.631 | 1 | A_assoc | 1 | 81.5 | 0 | 0 | 1 | 3 | 35415885, 33536494, 7547864 | 0 | cancer | 0.6026669167438079 | ||
| O95445 | APOM | Apolipoprotein M | Tier 1.5 | 0.631 | 1 | A_assoc | 3 | 89.44 | 0 | 0 | 1 | 10 | 38238732, 36980195, 35120890, 32237898, 30771967, 37425696, 37400771, 34796696 | 1 | type 2 diabetes mellitus | 0.10169659060091507 | ||
| Q9GZX6 | IL22 | Interleukin-22 | Tier 1.5 | 0.619 | 1 | A_assoc | 6 | 88.12 | 0 | 0 | 1 | 7 | 34208021, 33869115, 28942363, 26792955, 37041650 | 0 | atopic eczema | 0.5627493881195745 | ||
| Q15726 | KISS1 | Metastasis-suppressor KiSS-1 | Tier 1.5 | 0.618 | 1 | A_assoc | 2 | 59.41 | 1 | 0 | 1 | 1 | 35026192 | 0 | hypogonadotropic hypogonadism | 0.5608645918536114 | ||
| P22466 | GAL | Galanin peptides | Tier 1.5 | 0.613 | 1 | A_assoc | 10 | 66.56 | 1 | 0 | 1 | 27 | 40382399, 40371468, 39772541, 39705316, 39681229, 39430968, 39329806, 39263318, 38487245, 38314707, 37737989, 37610431, 37512948, 36795559, 36194889, 34944985, 34635237, 33769582, 33006019, 32502344, 31778957, 31173420, 30650243, 29808997, 25940316, 21850727, 9546673 | 0 | temporal lobe epilepsy | 0.5442263564708273 | ||
| P02766 | TTR | Transthyretin | Tier 1.5 | 0.609 | 0 | A_assoc | 0 | 88.0 | 0 | 0 | 1 | 11 | 39737993, 32616928, 23770039, 21875107, 21314458, 39596348, 38399458, 36881759, 33572452 | 1 | amyloidosis, hereditary systemic 1 | 0.846421986844374 | ||
| P56703 | WNT3 | Proto-oncogene Wnt-3 | Tier 1.5 | 0.608 | 1 | A_assoc | 1 | 88.25 | 0 | 0 | 1 | 2 | 40168709, 18673242 | 0 | neurodegenerative disease | 0.5272184953415704 | ||
| P43251 | BTD | Biotinidase | Tier 1.5 | 0.607 | 0 | A_assoc | 0 | 86.19 | 0 | 0 | 1 | 1 | 27628341 | 1 | biotinidase deficiency | 0.8394965674633185 | ||
| P02654 | APOC1 | Apolipoprotein C-I | Tier 1.5 | 0.6 | 1 | A_assoc | 8 | 70.69 | 0 | 0 | 1 | 4 | 41316897, 40501769, 35415203, 15132764 | 1 | ||||
| P24855 | DNASE1 | Deoxyribonuclease-1 | Tier 1.5 | 0.591 | 1 | A_assoc | 1 | 94.25 | 0 | 0 | 1 | 1 | 36838023 | 0 | systemic lupus erythematosus | 0.4692224712894944 | ||
| P41271 | NBL1 | Neuroblastoma suppressor of tumorigenicity 1 | Tier 1.5 | 0.585 | 1 | A_assoc | 2 | 75.75 | 0 | 0 | 1 | 2 | 35026285, 29281176 | 0 | nontoxic goiter | 0.44859094265791405 | ||
| P18075 | BMP7 | Bone morphogenetic protein 7 | Tier 1.5 | 0.583 | 1 | A_assoc | 4 | 76.19 | 0 | 0 | 1 | 1 | 30537181 | 0 | Inguinal hernia | 0.4420059023371716 | ||
| P01031 | C5 | Complement C5 | Tier 1.5 | 0.58 | 0 | A_assoc | 0 | 81.56 | 0 | 0 | 1 | 58 | 41407269, 41159487, 40915733, 40683108, 40479828, 40243681, 39831626, 39318191, 39263947, 39073397, 38694318, 38179195, 37566081, 35442665, 35056853, 34637287, 33398182, 33039563, 32882310, 32784904, 32463617, 31862877, 31460550, 31301466, 31184617, 30810582, 30633241, 29850750, 29846697, 29341876, 29294056, 28918528, 28104543, 26947566, 26838458, 26221631, 26057195, 23887360, 23662585, 23595830, 19843610, 19469583, 17263432, 16518777, 15745996, 14980623, 14552769, 12903182, 12490703, 10408383 | 1 | Immunodeficiency due to a late component of complements deficiency | 0.7500698741801265 | ||
| Q8NEV9 | IL27 | Interleukin-27 subunit alpha | Tier 1.5 | 0.573 | 1 | A_assoc | 4 | 75.62 | 1 | 0 | 1 | 2 | 35859339, 32784904 | 0 | Crohn's disease | 0.40963715551754365 | ||
| P41221 | WNT5A | Protein Wnt-5a | Tier 1.5 | 0.572 | 0 | A_assoc | 0 | 87.69 | 0 | 0 | 1 | 4 | 40855286, 32693649, 22363130, 18673242 | 1 | Robinow syndrome | 0.7220360983378594 | ||
| O95750 | FGF19 | Fibroblast growth factor 19 | Tier 1.5 | 0.566 | 1 | A_assoc | 4 | 79.81 | 0 | 0 | 1 | 4 | 35415885, 31967847, 27679852 | 0 | cancer | 0.38540691230511315 | ||
| P35443 | THBS4 | Thrombospondin-4 | Tier 1.5 | 0.559 | 0 | A_assoc | 0 | 84.56 | 0 | 0 | 1 | 3 | 28252048, 38045440, 32527800 | 1 | Abnormality of the skeletal system | 0.6783866364728552 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;